Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome

References

• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421.
   Google Scholar
• Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–1062.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.
   Google Scholar
• Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629–636.
   PubMed Web of Science ®Google Scholar
• Chaabo F, Pronczuk A, Maslova E, Hayes K. Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome. Nutr Metab (Lond) 2010;7:29.
   PubMedGoogle Scholar
• Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 2009;92:1171–1186.
   PubMed Web of Science ®Google Scholar
• Vassalle C, Simoncini T, Chedraui P, Pérez-López FR. Why sex matters: the biological mechanisms of cardiovascular disease. Gynecol Endocrinol (In Press).
   Google Scholar
• Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447–454.
   PubMed Web of Science ®Google Scholar
• Koh KK, Quon MJ, Han SH, Chung WJ, Kim JA, Shin EK. Vascular and metabolic effects of candesartan: insights from therapeutic interventions. J Hypertens Suppl 2006;24:S31–S38.
   PubMedGoogle Scholar
• Espinola-Klein C, Gori T, Blankenberg S, Munzel T. Inflammatory markers and cardiovascular risk in the metabolic syndrome. Front Biosci 2011;16:1663–1674.
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006;147 Suppl 1:S193–S201.
   PubMed Web of Science ®Google Scholar
• Siervo M, Bluck LJ. In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome. Metab Clin Exp (In Press).
   Google Scholar
• Garlichs CD, Beyer J, Zhang H, Schmeisser A, Plötze K, Mügge A, Schellong S, Daniel WG. Decreased plasma concentrations of l-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors. J Lab Clin Med 2000;135:419–425.
   PubMedGoogle Scholar
• Kleinbongard P, Dejam A, Lauer T, Jax T, Kerber S, Gharini P, Balzer J, et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 2006;40:295–302.
   PubMed Web of Science ®Google Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332–341.
   PubMed Web of Science ®Google Scholar
• Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1–16.
   PubMed Web of Science ®Google Scholar
• Sites CK, Toth MJ, Cushman M, L’Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002;77:128–135.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Jaramillo W, Pérez-López FR, Escobar GS, Morocho N, Hidalgo L. Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol 2011;27:685–691.
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Blümel JE, Roncagliolo ME, Haya J, Bolf D, Binfa L, Tacla X, Colodrón M. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45:205–212.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity and overweight. Fact sheet N°311. http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 1 February 2012.
   Google Scholar
• Devaraj S, Siegel D, Jialal I. Inflammation and metabolic syndrome. In: Byrne CD, Wild SH, editors. The metabolic syndrome; 2011. pp 210–228.
   Google Scholar
• Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 2000;275:715–719.
   PubMed Web of Science ®Google Scholar
• Siervo M, Jackson SJ, Bluck LJ. In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. J Hypertens 2011;29:1515–1527.
   PubMed Web of Science ®Google Scholar
• Teran E, Chedraui P, Vivero S, Villena F, Duchicela F, Nacevilla L. Plasma and placental nitric oxide levels in women with and without pre-eclampsia living at different altitudes. Int J Gynaecol Obstet 2009;104:140–142.
   PubMed Web of Science ®Google Scholar
• Sharma D, Singh A, Trivedi SS, Bhattacharjee J. Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Hum Immunol 2011;72:436–439.
   PubMed Web of Science ®Google Scholar
• Forest JC, Girouard J, Massé J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005;105:1373–1380.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
   PubMed Web of Science ®Google Scholar
• Giguère Y, Charland M, Thériault S, Bujold E, Laroche M, Rousseau F, Lafond J, Forest JC. Review: Linking preeclampsia and cardiovascular disease later in life. Clin Chem Lab Med (In Press).
   Google Scholar
• Stelzer I, Zelzer S, Raggam RB, Prüller F, Truschnig-Wilders M, Meinitzer A, Schnedl WJ, et al. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 2012;159:118–124.
   PubMed Web of Science ®Google Scholar
• Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009;58:727–736.
   PubMed Web of Science ®Google Scholar
• Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745–E751.
   PubMed Web of Science ®Google Scholar